{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "CitationSubset": ["IM"], "OtherAbstract": [], "KeywordList": [], "GeneralNote": [], "OtherID": [], "InvestigatorList": [], "PMID": "30842540", "DateCompleted": {"Year": "2020", "Month": "09", "Day": "23"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "03", "Day": "06"}], "Language": ["eng"], "ELocationID": ["3641", "10.1038/s41598-019-40343-w"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "9", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Mar", "Day": "06"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Ultrafine particles and ozone perturb norepinephrine clearance rather than centrally generated sympathetic activity in humans.", "Pagination": {"StartPage": "3641", "MedlinePgn": "3641"}, "Abstract": {"AbstractText": ["Cardiovascular risk rapidly increased following exposure to air pollution. Changes in human autonomic regulation have been implicated based on epidemiological associations between exposure estimates and indirect autonomic nervous system measurements. We conducted a mechanistic study to test the hypothesis that, in healthy older individuals, well-defined experimental exposure to ultrafine carbon particles (UFP) increases sympathetic nervous system activity and more so with added ozone (O<sub>3</sub>). Eighteen participants (age >50 years, 6 women) were exposed to filtered air (Air), UFP, and UFP\u2009+\u2009O<sub>3</sub> combination for 3\u2009hours during intermittent bicycle ergometer training in a randomized, crossover, double-blind fashion. Two hours following exposure, respiration, electrocardiogram, blood pressure, and muscle sympathetic nerve activity (MSNA) were recorded at supine rest, during deep breathing, and during a Valsalva manoeuvre. Catechols and inflammatory marker levels were measured in venous blood samples. Induced sputum was obtained 3.5\u2009h after exposure. Combined exposure to UFP\u2009+\u2009O<sub>3</sub> but not UFP alone, caused a significant increase in sputum neutrophils and circulating leucocytes. Norepinephrine was modestly increased while the ratio between plasma dihydroxyphenylglycol (DHPG) and norepinephrine levels, a marker for norepinephrine clearance, was reduced with UFP\u2009+\u2009O<sub>3</sub>. Resting MSNA was not different (47\u2009\u00b1\u200912 with Air, 47\u2009\u00b1\u200914 with UFP, and 45\u2009\u00b1\u200914 bursts/min with UFP\u2009+\u2009O<sub>3</sub>). Indices of parasympathetic heart rate control were unaffected by experimental air pollution. Our study suggests that combined exposure to modest UFP and O<sub>3</sub> levels increases peripheral norepinephrine availability through decreased clearance rather than changes in central autonomic activity. Pulmonary inflammatory response may have perturbed pulmonary endothelial norepinephrine clearance."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Aerospace Medicine, German Aerospace Center (DLR), 51147, Cologne, Germany."}], "Identifier": ["0000-0002-2571-5585"], "LastName": "Heusser", "ForeName": "Karsten", "Initials": "K"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Aerospace Medicine, German Aerospace Center (DLR), 51147, Cologne, Germany."}], "Identifier": ["0000-0002-5672-1187"], "LastName": "Tank", "ForeName": "Jens", "Initials": "J"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), 30625, Hannover, Germany."}, {"Identifier": [], "Affiliation": "Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research, 30625, Hannover, Germany."}], "Identifier": [], "LastName": "Holz", "ForeName": "Olaf", "Initials": "O"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "MHH CRC Core Facility & Centre for Pharmacology and Toxicology, Hannover Medical School, 30625, Hannover, Germany."}], "Identifier": ["0000-0002-7513-4244"], "LastName": "May", "ForeName": "Marcus", "Initials": "M"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute for Clinical Pharmacology, Hannover Medical School, 30625, Hannover, Germany."}, {"Identifier": [], "Affiliation": "Kaufm\u00e4nnische Krankenkasse - KKH, Karl-Wiechert-Allee 61, 30625, Hannover, Germany."}], "Identifier": [], "LastName": "Brinkmann", "ForeName": "Julia", "Initials": "J"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute for Clinical Pharmacology, Hannover Medical School, 30625, Hannover, Germany."}], "Identifier": [], "LastName": "Engeli", "ForeName": "Stefan", "Initials": "S"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Division of Clinical Pharmacology, Autonomic Dysfunction Center, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA."}], "Identifier": ["0000-0001-5643-0294"], "LastName": "Diedrich", "ForeName": "Andr\u00e9", "Initials": "A"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biostatistics, Hannover Medical School, 30625, Hannover, Germany."}], "Identifier": [], "LastName": "Framke", "ForeName": "Theodor", "Initials": "T"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biostatistics, Hannover Medical School, 30625, Hannover, Germany."}], "Identifier": [], "LastName": "Koch", "ForeName": "Armin", "Initials": "A"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biostatistics, Hannover Medical School, 30625, Hannover, Germany."}], "Identifier": [], "LastName": "Gro\u00dfhennig", "ForeName": "Anika", "Initials": "A"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus Medical Center, 3015 GE, Rotterdam, The Netherlands."}], "Identifier": [], "LastName": "Jan Danser", "ForeName": "A H", "Initials": "AH"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Laboratory Medicine, Radboud University Medical Centre, 6500 HB, Nijmegen, The Netherlands."}], "Identifier": ["0000-0003-1103-3070"], "LastName": "Sweep", "ForeName": "Fred C G J", "Initials": "FCGJ"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "MHH CRC Core Facility & Centre for Pharmacology and Toxicology, Hannover Medical School, 30625, Hannover, Germany."}], "Identifier": [], "LastName": "Schindler", "ForeName": "Christoph", "Initials": "C"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), 30625, Hannover, Germany."}], "Identifier": [], "LastName": "Schwarz", "ForeName": "Katharina", "Initials": "K"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), 30625, Hannover, Germany."}, {"Identifier": [], "Affiliation": "Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research, 30625, Hannover, Germany."}], "Identifier": [], "LastName": "Krug", "ForeName": "Norbert", "Initials": "N"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Aerospace Medicine, German Aerospace Center (DLR), 51147, Cologne, Germany. jens.jordan@dlr.de."}], "Identifier": [], "LastName": "Jordan", "ForeName": "Jens", "Initials": "J"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), 30625, Hannover, Germany."}, {"Identifier": [], "Affiliation": "Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research, 30625, Hannover, Germany."}, {"Identifier": [], "Affiliation": "Department of Respiratory Medicine, Hannover Medical School, 30625, Hannover, Germany."}], "Identifier": [], "LastName": "Hohlfeld", "ForeName": "Jens M", "Initials": "JM"}], "GrantList": [{"GrantID": "P01 HL056693", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL142583", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "R56 HL142583", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Randomized Controlled Trial", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Air Pollutants"}, {"RegistryNumber": "0", "NameOfSubstance": "Particulate Matter"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "X4W3ENH1CV", "NameOfSubstance": "Norepinephrine"}], "MeshHeadingList": [{"QualifierName": ["adverse effects"], "DescriptorName": "Air Pollutants"}, {"QualifierName": [], "DescriptorName": "Cross-Over Studies"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Inhalation Exposure"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["metabolism"], "DescriptorName": "Norepinephrine"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ozone"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Particulate Matter"}, {"QualifierName": ["chemically induced", "metabolism", "pathology"], "DescriptorName": "Pneumonia"}, {"QualifierName": ["drug effects"], "DescriptorName": "Sympathetic Nervous System"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "World Health Organisation World Health Report: reducing risks and promoting healthy life. (2002)."}, {"Citation": "Pope CA, III, et al. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation. 2004;109:71\u201377. doi: 10.1161/01.CIR.0000108927.80044.7F.", "ArticleIdList": ["10.1161/01.CIR.0000108927.80044.7F", "14676145"]}, {"Citation": "Peters A, Dockery DW, Muller JE, Mittleman MA. Increased particulate air pollution and the triggering of myocardial infarction. Circulation. 2001;103:2810\u20132815. doi: 10.1161/01.CIR.103.23.2810.", "ArticleIdList": ["10.1161/01.CIR.103.23.2810", "11401937"]}, {"Citation": "Rich DQ, et al. Association of short-term ambient air pollution concentrations and ventricular arrhythmias. Am. J. Epidemiol. 2005;161:1123\u20131132. doi: 10.1093/aje/kwi143.", "ArticleIdList": ["10.1093/aje/kwi143", "15937021"]}, {"Citation": "Peters A, et al. Increases in heart rate during an air pollution episode. Am. J. Epidemiol. 1999;150:1094\u20131098. doi: 10.1093/oxfordjournals.aje.a009934.", "ArticleIdList": ["10.1093/oxfordjournals.aje.a009934", "10568625"]}, {"Citation": "Ibald-Mulli A, Stieber J, Wichmann HE, Koenig W, Peters A. Effects of air pollution on blood pressure: a population-based approach. Am. J. Public Health. 2001;91:571\u2013577. doi: 10.2105/AJPH.91.9.1346.", "ArticleIdList": ["10.2105/AJPH.91.9.1346", "PMC1446632", "11291368"]}, {"Citation": "Magari SR, et al. Association of heart rate variability with occupational and environmental exposure to particulate air pollution. Circulation. 2001;104:986\u2013991. doi: 10.1161/hc3401.095038.", "ArticleIdList": ["10.1161/hc3401.095038", "11524390"]}, {"Citation": "Cavallari JM, et al. Time course of heart rate variability decline following particulate matter exposures in an occupational cohort. Inhal. Toxicol. 2008;20:415\u2013422. doi: 10.1080/08958370801903800.", "ArticleIdList": ["10.1080/08958370801903800", "18302049"]}, {"Citation": "Luttmann-Gibson H, et al. Short-term effects of air pollution on heart rate variability in senior adults in Steubenville, Ohio. J. Occup. Environ. Med. 2006;48:780\u2013788. doi: 10.1097/01.jom.0000229781.27181.7d.", "ArticleIdList": ["10.1097/01.jom.0000229781.27181.7d", "16902370"]}, {"Citation": "Gong H, Jr., et al. Altered heart-rate variability in asthmatic and healthy volunteers exposed to concentrated ambient coarse particles. Inhal. Toxicol. 2004;16:335\u2013343. doi: 10.1080/08958370490439470.", "ArticleIdList": ["10.1080/08958370490439470", "15204749"]}, {"Citation": "Niwa Y, Hiura Y, Sawamura H, Iwai N. Inhalation exposure to carbon black induces inflammatory response in rats. Circ. J. 2008;72:144\u2013149. doi: 10.1253/circj.72.144.", "ArticleIdList": ["10.1253/circj.72.144", "18159116"]}, {"Citation": "Sun Q, et al. Air pollution exposure potentiates hypertension through reactive oxygen species-mediated activation of Rho/ROCK. Arterioscler. Thromb. Vasc. Biol. 2008;28:1760\u20131766. doi: 10.1161/ATVBAHA.108.166967.", "ArticleIdList": ["10.1161/ATVBAHA.108.166967", "PMC2739008", "18599801"]}, {"Citation": "Li H, et al. Particulate matter exposure and stress hormone levels: A randomized, double-blind, crossover trial of air purification. Circulation. 2017;136:618\u2013627. doi: 10.1161/CIRCULATIONAHA.116.026796.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.116.026796", "28808144"]}, {"Citation": "Devlin RB, Ghio AJ, Kehrl H, Sanders G, Cascio W. Elderly humans exposed to concentrated air pollution particles have decreased heart rate variability. Eur. Respir. J. Suppl. 2003;40:76s\u201380s. doi: 10.1183/09031936.03.00402403.", "ArticleIdList": ["10.1183/09031936.03.00402403", "12762579"]}, {"Citation": "Gold DR, et al. Ambient pollution and heart rate variability. Circulation. 2000;101:1267\u20131273. doi: 10.1161/01.CIR.101.11.1267.", "ArticleIdList": ["10.1161/01.CIR.101.11.1267", "10725286"]}, {"Citation": "Oberdorster G, et al. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol. 2004;16:437\u2013445. doi: 10.1080/08958370490439597.", "ArticleIdList": ["10.1080/08958370490439597", "15204759"]}, {"Citation": "Alexeeff SE, et al. Ozone exposure, antioxidant genes, and lung function in an elderly cohort: VA normative aging study. Occup. Environ. Med. 2008;65:736\u2013742. doi: 10.1136/oem.2007.035253.", "ArticleIdList": ["10.1136/oem.2007.035253", "PMC2575239", "18524839"]}, {"Citation": "Traboulsi, H. et al. Inhaled Pollutants: The molecular scene behind respiratory and systemic diseases associated with ultrafine particulate matter. Int. J. Mol. Sci. 18 (2017).", "ArticleIdList": ["PMC5343780", "28125025"]}, {"Citation": "Janssen, N.A.H. et al. Health effects of black carbon. 86 (WHO Regional Office for Europe, 2012)."}, {"Citation": "Chuang KJ, Chan CC, Su TC, Lee CT, Tang CS. The effect of urban air pollution on inflammation, oxidative stress, coagulation, and autonomic dysfunction in young adults. Am. J. Respir. Crit. Care Med. 2007;176:370\u2013376. doi: 10.1164/rccm.200611-1627OC.", "ArticleIdList": ["10.1164/rccm.200611-1627OC", "17463411"]}, {"Citation": "Brook RD, et al. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation. 2002;105:1534\u20131536. doi: 10.1161/01.CIR.0000013838.94747.64.", "ArticleIdList": ["10.1161/01.CIR.0000013838.94747.64", "11927516"]}, {"Citation": "Bell ML, McDermott A, Zeger SL, Samet JM, Dominici F. Ozone and short-term mortality in 95 US urban communities, 1987-2000. JAMA. 2004;292:2372\u20132378. doi: 10.1001/jama.292.19.2372.", "ArticleIdList": ["10.1001/jama.292.19.2372", "PMC3546819", "15547165"]}, {"Citation": "Jakab GJ, Hemenway DR. Concomitant exposure to carbon black particulates enhances ozone-induced lung inflammation and suppression of alveolar macrophage phagocytosis. J. Toxicol. Environ. Health. 1994;41:221\u2013231. doi: 10.1080/15287399409531838.", "ArticleIdList": ["10.1080/15287399409531838", "8301700"]}, {"Citation": "Schaumann F, et al. Effects of ultrafine particles on the allergic inflammation in the lung of asthmatics: results of a double-blinded randomized cross-over clinical pilot study. Part. Fibre Toxicol. 2014;11:39. doi: 10.1186/s12989-014-0039-3.", "ArticleIdList": ["10.1186/s12989-014-0039-3", "PMC4354282", "25204642"]}, {"Citation": "Lippmann M. Health effects of ozone. A critical review. JAPCA. 1989;39:672\u2013695. doi: 10.1080/08940630.1989.10466554.", "ArticleIdList": ["10.1080/08940630.1989.10466554", "2659744"]}, {"Citation": "Mudway IS, Kelly FJ. An investigation of inhaled ozone dose and the magnitude of airway inflammation in healthy adults. Am. J. Respir. Crit. Care Med. 2004;169:1089\u20131095. doi: 10.1164/rccm.200309-1325PP.", "ArticleIdList": ["10.1164/rccm.200309-1325PP", "14754762"]}, {"Citation": "Holz O, et al. Ozone-induced airway inflammatory changes differ between individuals and are reproducible. Am. J. Respir. Crit. Care Med. 1999;159:776\u2013784. doi: 10.1164/ajrccm.159.3.9806098.", "ArticleIdList": ["10.1164/ajrccm.159.3.9806098", "10051250"]}, {"Citation": "Willemsen JJ, Sweep CG, Lenders JW, Ross HA. Stability of plasma free metanephrines during collection and storage as assessed by an optimized HPLC method with electrochemical detection. Clin. Chem. 2003;49:1951\u20131953. doi: 10.1373/clinchem.2003.023135.", "ArticleIdList": ["10.1373/clinchem.2003.023135", "14578334"]}, {"Citation": "Danser AH, et al. Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J. Hypertens. 1998;16:853\u2013862. doi: 10.1097/00004872-199816060-00017.", "ArticleIdList": ["10.1097/00004872-199816060-00017", "9663926"]}, {"Citation": "Zoerner AA, et al. Unique pentafluorobenzylation and collision-induced dissociation for specific and accurate GC-MS/MS quantification of the catecholamine metabolite 3,4-dihydroxyphenylglycol (DHPG) in human urine. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2011;879:1444\u20131456. doi: 10.1016/j.jchromb.2010.06.022.", "ArticleIdList": ["10.1016/j.jchromb.2010.06.022", "20638915"]}, {"Citation": "Holz O, et al. Efficacy and safety of inhaled calcium lactate PUR118 in the ozone challenge model\u2013a clinical trial. BMC Pharmacol. Toxicol. 2015;16:21. doi: 10.1186/s40360-015-0021-1.", "ArticleIdList": ["10.1186/s40360-015-0021-1", "PMC4533952", "26265479"]}, {"Citation": "Bertinieri G, et al. A new approach to analysis of the arterial baroreflex. J. Hypertens. Suppl. 1985;3(Suppl):79\u201381.", "ArticleIdList": ["2856787"]}, {"Citation": "Hills M, Armitage P. The two-period cross-over clinical trial. Br. J. Clin. Pharmacol. 1979;8:7\u201320. doi: 10.1111/j.1365-2125.1979.tb05903.x.", "ArticleIdList": ["10.1111/j.1365-2125.1979.tb05903.x", "PMC1429717", "552299"]}, {"Citation": "Bromberg PA. Mechanisms of the acute effects of inhaled ozone in humans. Biochim. Biophys. Acta. 2016;1860:2771\u20132781. doi: 10.1016/j.bbagen.2016.07.015.", "ArticleIdList": ["10.1016/j.bbagen.2016.07.015", "27451958"]}, {"Citation": "Zevin S, Saunders S, Gourlay SG, Jacob P, Benowitz NL. Cardiovascular effects of carbon monoxide and cigarette smoking. J. Am. Coll. Cardiol. 2001;38:1633\u20131638. doi: 10.1016/S0735-1097(01)01616-3.", "ArticleIdList": ["10.1016/S0735-1097(01)01616-3", "11704374"]}, {"Citation": "Stewart JC, et al. Vascular effects of ultrafine particles in persons with type 2 diabetes. Environ. Health Perspect. 2010;118:1692\u20131698. doi: 10.1289/ehp.1002237.", "ArticleIdList": ["10.1289/ehp.1002237", "PMC3002188", "20822968"]}, {"Citation": "Tank J, et al. Effect of acute ozone induced airway inflammation on human sympathetic nerve traffic: a randomized, placebo controlled, crossover study. PLoS One. 2011;6:e18737. doi: 10.1371/journal.pone.0018737.", "ArticleIdList": ["10.1371/journal.pone.0018737", "PMC3073001", "21494635"]}, {"Citation": "Stenfors N, et al. Effect of ozone on bronchial mucosal inflammation in asthmatic and healthy subjects. Respir. Med. 2002;96:352\u2013358. doi: 10.1053/rmed.2001.1265.", "ArticleIdList": ["10.1053/rmed.2001.1265", "12113386"]}, {"Citation": "Aris RM, et al. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am. Rev. Respir. Dis. 1993;148:1363\u20131372. doi: 10.1164/ajrccm/148.5.1363.", "ArticleIdList": ["10.1164/ajrccm/148.5.1363", "8239177"]}, {"Citation": "Coleridge JC, Coleridge HM, Schelegle ES, Green JF. Acute inhalation of ozone stimulates bronchial C-fibers and rapidly adapting receptors in dogs. J. Appl. Physiol. 1993;74:2345\u20132352. doi: 10.1152/jappl.1993.74.5.2345.", "ArticleIdList": ["10.1152/jappl.1993.74.5.2345", "8335566"]}, {"Citation": "Kreyling WG, Semmler M, Moller W. Dosimetry and toxicology of ultrafine particles. J. Aerosol. Med. 2004;17:140\u2013152. doi: 10.1089/0894268041457147.", "ArticleIdList": ["10.1089/0894268041457147", "15294064"]}, {"Citation": "Semmler M, et al. Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal. Toxicol. 2004;16:453\u2013459. doi: 10.1080/08958370490439650.", "ArticleIdList": ["10.1080/08958370490439650", "15204761"]}, {"Citation": "Vincent S, et al. Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles. Circulation. 2004;109:3202\u20133207. doi: 10.1161/01.CIR.0000130847.18666.39.", "ArticleIdList": ["10.1161/01.CIR.0000130847.18666.39", "15184278"]}, {"Citation": "Shannon JR, et al. Orthostatic intolerance and tachycardia associated with norepinephrine transporter deficiency. N. Engl. J. Med. 2000;342:541\u2013549. doi: 10.1056/NEJM200002243420803.", "ArticleIdList": ["10.1056/NEJM200002243420803", "10684912"]}, {"Citation": "Boschmann M, et al. Norepinephrine transporter function and autonomic control of metabolism. J. Clin. Endocrinol. Metab. 2002;87:5130\u20135137. doi: 10.1210/jc.2002-020533.", "ArticleIdList": ["10.1210/jc.2002-020533", "12414883"]}, {"Citation": "Schroeder C, et al. Norepinephrine transporter inhibition prevents tilt-induced pre-syncope. J. Am. Coll. Cardiol. 2006;48:516\u2013522. doi: 10.1016/j.jacc.2006.04.073.", "ArticleIdList": ["10.1016/j.jacc.2006.04.073", "16875978"]}, {"Citation": "Bieck PR, et al. Dihydroxyphenylglycol as a Biomarker of Norepinephrine Transporter Inhibition by Atomoxetine: Human Model to Assess Central and Peripheral Effects of Dosing. J. Clin. Psychopharmacol. 2016;36:675\u2013683. doi: 10.1097/JCP.0000000000000611.", "ArticleIdList": ["10.1097/JCP.0000000000000611", "27755221"]}, {"Citation": "Tseng YT, Padbury JF. Expression of a pulmonary endothelial norepinephrine transporter. J. Neural Transm. (Vienna) 1998;105:1187\u20131191. doi: 10.1007/s007020050121.", "ArticleIdList": ["10.1007/s007020050121", "9928887"]}, {"Citation": "Bryan-Lluka LJ, Westwood NN, O\u2019Donnell SR. Vascular uptake of catecholamines in perfused lungs of the rat occurs by the same process as Uptake1 in noradrenergic neurones. Naunyn Schmiedebergs Arch Pharmacol. 1992;345:319\u2013326. doi: 10.1007/BF00168693.", "ArticleIdList": ["10.1007/BF00168693", "1535692"]}, {"Citation": "Eisenhofer G. The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol. Ther. 2001;91:35\u201362. doi: 10.1016/S0163-7258(01)00144-9.", "ArticleIdList": ["10.1016/S0163-7258(01)00144-9", "11707293"]}, {"Citation": "Eisenhofer G, Smolich JJ, Esler MD. Different desipramine-sensitive pulmonary removals of plasma epinephrine and norepinephrine in dogs. Am. J. Physiol. 1992;262:L360\u2013365.", "ArticleIdList": ["1550259"]}, {"Citation": "Smolich JJ, Cox HS, Esler MD. Contribution of lungs to desipramine-induced changes in whole body catecholamine kinetics in newborn lambs. Am. J. Physiol. 1999;276:R243\u2013R250.", "ArticleIdList": ["9887202"]}, {"Citation": "Pope CA, III, et al. Exposure to fine particulate air pollution is associated with endothelial injury and systemic inflammation. Circ. Res. 2016;119:1204\u20131214. doi: 10.1161/CIRCRESAHA.116.309279.", "ArticleIdList": ["10.1161/CIRCRESAHA.116.309279", "PMC5215745", "27780829"]}, {"Citation": "Kristensen AS, et al. SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol. Rev. 2011;63:585\u2013640. doi: 10.1124/pr.108.000869.", "ArticleIdList": ["10.1124/pr.108.000869", "21752877"]}, {"Citation": "Steerenberg PA, et al. Relation between sources of particulate air pollution and biological effect parameters in samples from four European cities: an exploratory study. Inhal. Toxicol. 2006;18:333\u2013346. doi: 10.1080/08958370500515913.", "ArticleIdList": ["10.1080/08958370500515913", "16513592"]}, {"Citation": "Appleby P. Fresh air and indoor air quality: Pieces in the sick building puzzle? Facilities. 1989;7:7\u201311. doi: 10.1108/eb006513.", "ArticleIdList": ["10.1108/eb006513"]}, {"Citation": "Brook RD, et al. Insights into the mechanisms and mediators of the effects of air pollution exposure on blood pressure and vascular function in healthy humans. Hypertension. 2009;54:659\u2013667. doi: 10.1161/HYPERTENSIONAHA.109.130237.", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.109.130237", "PMC3706996", "19620518"]}, {"Citation": "Recio A, Linares C, Banegas JR, Diaz J. The short-term association of road traffic noise with cardiovascular, respiratory, and diabetes-related mortality. Environ. Res. 2016;150:383\u2013390. doi: 10.1016/j.envres.2016.06.014.", "ArticleIdList": ["10.1016/j.envres.2016.06.014", "27371929"]}]}], "History": [{"Year": "2018", "Month": "6", "Day": "19"}, {"Year": "2019", "Month": "2", "Day": "8"}, {"Year": "2019", "Month": "3", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["30842540", "PMC6403347", "10.1038/s41598-019-40343-w", "10.1038/s41598-019-40343-w"]}}]}